ProductDescription
TMC207(Bedaquiline)isadiarylquinoline-basedinhibitorofbacterialATPsynthaseatnanomolarconcentrations.InvitromycobacterialexperimentsshowthatTMC207inhibitsdrug-sensitiveanddrug-resistantmycobacterialTBatanMICrangeof2to60nMandanMIC50of30ng/mL.AdditionallyTMC207isbroadlypotentagainstmanynon-tuberculousmycobacteria,withMICsof6to500nM.(1)
StudiesshowthatTMC207isorally-availableandefficaciousonaonce-dailyadmiNISTrationforpatientswithpulmonaryTB.Noseriousadverseeventswereobserved.(2)
Technicalinformation:
| ChemicalFormula: | C32H31BrN2O2 | |
| CAS#: | 843663-66-1 | |
| MolecularWeight: | 555.5 | |
| Purity: | >98% | |
| Appearance: | white | |
| ChemicalName: | (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol | |
| Solubility: | Upto2mMinDMSO | |
| Synonyms: | TMC207,TMC-207,Bedaquiline |
ShippingCondition:Theproductisshippedinaglassvialatambienttemperature.
Storagecondition:Forlongershelflife,storesolidpowderat4oCdesiccated,orstoreDMSOsolutionat-20oC.
Reference:
| 1. | Matteellietal.,TMC207:thefirstcompoudnofanewclassofpotentanti-tuberculosisdrugs.FutureMicrobiol.2010,5(6),849-858.PubmedID:20521931 |
| 2. | Rustomjeeetal.,EarlyBactericidalActivityandPharmacokineticsoftheDiarylquinolineTMC207inTreatmentofPulmonaryTuberculosis.Antimicrob.AgentsChemother.2008,52(8),2831-2835.PubmedID:18505852 |
Cellagen的FlexiWash FW400自动膜/凝胶洗涤站设计用于自动Western blot膜洗涤和孵育过程。将蛋白质转移到膜上后,将膜加载到FlexiWash上以进行自动封闭,孵育和洗涤循环。用户只需要准备所需的试剂,启动印迹程序,然后让FW400进行其余操作即可。凭借独特的液体处理设计,FW400同时支持四个清洗/孵育过程,每个过程均可独立编程,并针对特定应用实现全自动。FW400也可用于蛋白质或DNA凝胶染色和脱色,或涉及重复液体处理和孵育周期的任何其他应用。


